754 related articles for article (PubMed ID: 35930586)
1. Hesitancy and reactogenicity to mRNA-based COVID-19 vaccines-Early experience with vaccine rollout in a multi-site healthcare system.
Al-Obaydi S; Hennrikus E; Mohammad N; Lehman EB; Thakur A; Al-Shaikhly T
PLoS One; 2022; 17(8):e0272691. PubMed ID: 35930586
[TBL] [Abstract][Full Text] [Related]
2. From trial to practice: incidence and severity of COVID-19 vaccine side effects in a medically at-risk and vaccine-hesitant community.
Joyce MC; Mountjoy NJ; Johnson JA; Newman JT; Bandy DL; Atalla NA; Singh A; McElroy D
BMC Public Health; 2022 Dec; 22(1):2351. PubMed ID: 36517842
[TBL] [Abstract][Full Text] [Related]
3. Allergic reactions to coronavirus disease 2019 vaccines and addressing vaccine hesitancy: Northwell Health experience.
Kaplan B; Farzan S; Coscia G; Rosenthal DW; McInerney A; Jongco AM; Ponda P; Bonagura VR
Ann Allergy Asthma Immunol; 2022 Feb; 128(2):161-168.e1. PubMed ID: 34699968
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 Vaccination Reactogenicity in Persons With Multiple Sclerosis.
Briggs FBS; Mateen FJ; Schmidt H; Currie KM; Siefers HM; Crouthamel S; Bebo BF; Fiol J; Racke MK; O'Connor KC; Kolaczkowski LG; Klein P; Loud S; McBurney RN
Neurol Neuroimmunol Neuroinflamm; 2022 Jan; 9(1):. PubMed ID: 34753828
[TBL] [Abstract][Full Text] [Related]
6. Perceptions and Concerns Regarding COVID-19 Vaccination in a Military Base Population.
Theis SR; Li PC; Kelly D; Ocampo T; Berglund A; Morgan D; Markert R; Fisher E; Burtson K
Mil Med; 2022 Oct; 187(11-12):e1255-e1260. PubMed ID: 34117501
[TBL] [Abstract][Full Text] [Related]
7. The impact of COVID-19 vaccine reactions on secondary vaccine hesitancy.
Freeman EE; Strahan AG; Smith LR; Judd AD; Samarakoon U; Chen G; King AJ; Blumenthal KG
Ann Allergy Asthma Immunol; 2024 May; 132(5):630-636.e1. PubMed ID: 38232816
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics.
Schwarzinger M; Watson V; Arwidson P; Alla F; Luchini S
Lancet Public Health; 2021 Apr; 6(4):e210-e221. PubMed ID: 33556325
[TBL] [Abstract][Full Text] [Related]
9. Curbing COVID-19 Vaccine Hesitancy from a Dermatological Standpoint: Analysis of Cutaneous Reactions in the Vaccine Adverse Event Reporting System (VAERS) Database.
Falotico JM; Desai AD; Shah A; Ricardo JW; Lipner SR
Am J Clin Dermatol; 2022 Sep; 23(5):729-737. PubMed ID: 35931925
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol.
Patel GB; Chhiba KD; Chen MM; Guo A; Watts MM; Cullen J; Bochner BS; Grammer LC; Greenberger PA; Saltoun CA; Stevens WW; Kuang FL; Peters AT
Allergy Asthma Proc; 2021 Nov; 42(6):515-521. PubMed ID: 34871159
[No Abstract] [Full Text] [Related]
11. Effect of gender, age and vaccine on reactogenicity and incapacity to work after COVID-19 vaccination: a survey among health care workers.
Nachtigall I; Bonsignore M; Hohenstein S; Bollmann A; Günther R; Kodde C; Englisch M; Ahmad-Nejad P; Schröder A; Glenz C; Kuhlen R; Thürmann P; Meier-Hellmann A
BMC Infect Dis; 2022 Mar; 22(1):291. PubMed ID: 35346089
[TBL] [Abstract][Full Text] [Related]
12. Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US.
Hause AM; Zhang B; Yue X; Marquez P; Myers TR; Parker C; Gee J; Su J; Shimabukuro TT; Shay DK
JAMA Netw Open; 2022 Jul; 5(7):e2222241. PubMed ID: 35838667
[TBL] [Abstract][Full Text] [Related]
13. Association of Self-reported High-Risk Allergy History With Allergy Symptoms After COVID-19 Vaccination.
Li L; Robinson LB; Patel R; Landman AB; Fu X; Shenoy ES; Hashimoto DM; Banerji A; Wickner PG; Samarakoon U; Mancini CM; Zhang Y; Blumenthal KG
JAMA Netw Open; 2021 Oct; 4(10):e2131034. PubMed ID: 34698847
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 Vaccine Hesitancy and Acceptance Among Individuals With Cancer, Autoimmune Diseases, or Other Serious Comorbid Conditions: Cross-sectional, Internet-Based Survey.
Tsai R; Hervey J; Hoffman K; Wood J; Johnson J; Deighton D; Clermont D; Loew B; Goldberg SL
JMIR Public Health Surveill; 2022 Jan; 8(1):e29872. PubMed ID: 34709184
[TBL] [Abstract][Full Text] [Related]
15. Coronavirus disease 2019 vaccine administration in patients with reported reactions to polyethylene glycol- and polysorbate-containing therapeutics.
Otani IM; Tsao LR; Tang M
Ann Allergy Asthma Immunol; 2022 Jul; 129(1):88-94.e1. PubMed ID: 35288274
[TBL] [Abstract][Full Text] [Related]
16. Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system.
Chapin-Bardales J; Myers T; Gee J; Shay DK; Marquez P; Baggs J; Zhang B; Licata C; Shimabukuro TT
Vaccine; 2021 Nov; 39(48):7066-7073. PubMed ID: 34763946
[TBL] [Abstract][Full Text] [Related]
17. Population-Based Incidence, Severity, and Risk Factors Associated with Treated Acute-Onset COVID-19 mRNA Vaccination-Associated Hypersensitivity Reactions.
Macy E; Pandya S; Sheikh J; Burnette A; Shi JM; Chung J; Gin N; Crawford W; Zhang J
J Allergy Clin Immunol Pract; 2022 Mar; 10(3):827-836. PubMed ID: 34971845
[TBL] [Abstract][Full Text] [Related]
18. Expectations and Prior Experiences Associated With Adverse Effects of COVID-19 Vaccination.
Schäfer I; Oltrogge JH; Nestoriuc Y; Warren CV; Brassen S; Blattner M; Lühmann D; Tinnermann A; Scherer M; Büchel C
JAMA Netw Open; 2023 Mar; 6(3):e234732. PubMed ID: 36972051
[TBL] [Abstract][Full Text] [Related]
19. Delayed systemic urticarial reactions following mRNA COVID-19 vaccination.
Pitlick MM; Joshi AY; Gonzalez-Estrada A; Chiarella SE
Allergy Asthma Proc; 2022 Jan; 43(1):40-43. PubMed ID: 34983709
[No Abstract] [Full Text] [Related]
20. COVID-19 vaccination in patients with primary immunodeficiencies: an international survey on patient vaccine hesitancy and self-reported adverse events.
Pergent M; Haerynck F; Hoste L; Gardulf A
Front Immunol; 2023; 14():1166198. PubMed ID: 37143673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
